ES2089014T3 - Metodo de sintesis de oligonucleotidos adaptable a la sintesis en gran escala. - Google Patents

Metodo de sintesis de oligonucleotidos adaptable a la sintesis en gran escala.

Info

Publication number
ES2089014T3
ES2089014T3 ES90905919T ES90905919T ES2089014T3 ES 2089014 T3 ES2089014 T3 ES 2089014T3 ES 90905919 T ES90905919 T ES 90905919T ES 90905919 T ES90905919 T ES 90905919T ES 2089014 T3 ES2089014 T3 ES 2089014T3
Authority
ES
Spain
Prior art keywords
phosphonate
oligonucleotides
sealing
synthesis
activating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90905919T
Other languages
English (en)
Inventor
Sudhir Agrawal
Paul C Zamecnik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Worcester Foundation for Biomedical Research
Original Assignee
Worcester Foundation for Biomedical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Worcester Foundation for Biomedical Research filed Critical Worcester Foundation for Biomedical Research
Application granted granted Critical
Publication of ES2089014T3 publication Critical patent/ES2089014T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/0046—Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277—Apparatus
    • B01J2219/00279—Features relating to reactor vessels
    • B01J2219/00281—Individual reactor vessels
    • B01J2219/00286—Reactor vessels with top and bottom openings
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277—Apparatus
    • B01J2219/00351—Means for dispensing and evacuation of reagents
    • B01J2219/00389—Feeding through valves
    • B01J2219/00391—Rotary valves
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277—Apparatus
    • B01J2219/00497—Features relating to the solid phase supports
    • B01J2219/005—Beads
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/0059—Sequential processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/00596—Solid-phase processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/0068—Means for controlling the apparatus of the process
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718—Type of compounds synthesised
    • B01J2219/0072—Organic compounds
    • B01J2219/00722—Nucleotides
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B60/00—Apparatus specially adapted for use in combinatorial chemistry or with libraries
    • C40B60/14—Apparatus specially adapted for use in combinatorial chemistry or with libraries for creating libraries

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Abstract

SE PRESENTA UN METODO PARA PRODUCIR OLIGONUCLEOTIDOS A PEQUEÑA O GRAN ESCALA UTILIZANDO MONOMEROS DE NUCLEOXIDO H-FOSFONATO. EL METODO PUEDE UTILIZARSE PARA SINTETIZAR OLIGONUCLEOTIDOS DE CUALQUIER LONGITUD, INCLUYENDO OLIGODESOXIRIBONUCLEOTIDOS Y OLIGORIBONUCLEOTIDOS. EL METODO DA COMO RESULTADO UNA EFICIENCIA DE ACOPLAMIENTO MAYOR DEL 97% Y CONSUME SOLAMENTE DE DOS A TRES EQUIVALENTES DE MONOMERO ACTIVADOR POR REACCION DE ACOPLAMIENTO. ADEMAS, EL METODO NO PRECISA UN PASO DE OBTURACION APARTE NI UN REACTIVO DE OBTURACION PORQUE EL REACTIVO ACTIVADOR PROPORCIONA UNA FUNCION DE OBTURACION PROPIA PREVINIENDO DE ESE MODO EL ALARGAMIENTO DE SECUENCIAS FALLIDAS. LAS UNIONES DE H-FOSFONATO DEL OLIGONUCLEOTIDO SINTETIZADO COMPLETAMENTE PUEDEN SER OXIDADAS CON UNA VARIEDAD DE REACTIVOS PARA OBTENER O DIESTER DE FOSFONATO U OTROS TIPOS DE OLIGONUCLEOTIDOS MODIFICADOS.
ES90905919T 1989-04-06 1990-04-05 Metodo de sintesis de oligonucleotidos adaptable a la sintesis en gran escala. Expired - Lifetime ES2089014T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/334,679 US5149798A (en) 1989-04-06 1989-04-06 Process for synthesizing oligonucleotides and their analogs adaptable to large scale syntheses

Publications (1)

Publication Number Publication Date
ES2089014T3 true ES2089014T3 (es) 1996-10-01

Family

ID=23308303

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90905919T Expired - Lifetime ES2089014T3 (es) 1989-04-06 1990-04-05 Metodo de sintesis de oligonucleotidos adaptable a la sintesis en gran escala.

Country Status (10)

Country Link
US (1) US5149798A (es)
EP (1) EP0593422B1 (es)
JP (1) JPH04504420A (es)
AT (1) ATE137760T1 (es)
BR (1) BR9007268A (es)
CA (1) CA2051692A1 (es)
DE (1) DE69026963T2 (es)
DK (1) DK0593422T3 (es)
ES (1) ES2089014T3 (es)
WO (1) WO1990012024A1 (es)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5149797A (en) * 1990-02-15 1992-09-22 The Worcester Foundation For Experimental Biology Method of site-specific alteration of rna and production of encoded polypeptides
EP0588881A1 (en) * 1991-05-10 1994-03-30 HYBRIDON, Inc. 3'-end blocked oligonucleotides
US5977343A (en) * 1992-05-14 1999-11-02 Ribozyme Pharmaceuticals, Inc. Synthesis, deprotection, analysis and purification of RNA and ribozymes
TW244371B (es) * 1992-07-23 1995-04-01 Tri Clover Inc
US6346614B1 (en) * 1992-07-23 2002-02-12 Hybridon, Inc. Hybrid oligonucleotide phosphorothioates
US6087491A (en) * 1993-01-08 2000-07-11 Hybridon, Inc. Extremely high purity oligonucleotides and methods of synthesizing them using dimer blocks
AU678821B2 (en) * 1993-01-08 1997-06-12 Hybridon, Inc. Detection of synthetic oligonucleotides extracted from body fluids or tissues
WO1995009236A1 (en) * 1993-09-28 1995-04-06 The General Hospital Corporation USING ANTISENSE OLIGONUCLEOTIDES TO MODULATE NERVE GROWTH AND TO REVERSE β/A4 AMYLOID-INDUCED MORPHOLOGY
US5550047A (en) * 1994-02-18 1996-08-27 University Of Massachusetts Oligonucleotides with anti-Epstein-Barr virus activity
US5801235A (en) * 1994-05-25 1998-09-01 Hybridon, Inc. Oligonucleotides with anti-cytomegalovirus activity
US5866699A (en) * 1994-07-18 1999-02-02 Hybridon, Inc. Oligonucleotides with anti-MDR-1 gene activity
WO1996003417A1 (en) * 1994-07-25 1996-02-08 Hybridon, Inc. Improved methods of detritylation for oligonucleotide synthesis
US5554744A (en) * 1994-09-23 1996-09-10 Hybridon, Inc. Method for loading solid supports for nucleic acid synthesis
US5833944A (en) * 1994-11-07 1998-11-10 Hybridon, Inc. Procedure for the solid phase synthesis of 35 S-labeled oligonucleotides with 3H-1,2-benzodithiol-3-one-1,1-dioxide
US6117993A (en) * 1995-05-23 2000-09-12 Hybridon, Inc. Synthons for oligonucleotide synthesis
US5750674A (en) * 1995-05-23 1998-05-12 Hybridon, Inc. Methods and compounds for the stereoselective enrichment of oligonucleotide diastereomers and oligonucleotides thereby produced
US6509459B1 (en) 1995-06-01 2003-01-21 Hybridon, Inc. Base protecting groups and rapid process for oligonucleotide synthesis
US6140482A (en) * 1995-06-01 2000-10-31 Hybridon, Inc. Primary phosphoramidate internucleoside linkages and oligonucleotides containing the same
US5955599A (en) * 1995-06-01 1999-09-21 Hybridon, Inc. Process for making oligonucleotides containing o- and s- methylphosphotriester internucleoside linkages
US5614622A (en) * 1995-06-01 1997-03-25 Hybridon, Inc. 5-pentenoyl moiety as a nucleoside-amino protecting group, 4-pentenoyl-protected nucleotide synthons, and related oligonucleotide syntheses
US6667293B1 (en) 1995-09-12 2003-12-23 Hybridon, Inc. Use of cyclodextrins to modulate gene expression with reduced immunostimulatory response
KR19990064332A (ko) 1995-10-19 1999-07-26 래리 더블유. 스미스, 코크란 아담 올리고뉴클레오티드의 액상 합성법
WO1998041531A2 (en) 1997-03-20 1998-09-24 University Of Washington Solvent for biopolymer synthesis, solvent microdroplets and methods of use
US6419883B1 (en) 1998-01-16 2002-07-16 University Of Washington Chemical synthesis using solvent microdroplets
US6028189A (en) * 1997-03-20 2000-02-22 University Of Washington Solvent for oligonucleotide synthesis and methods of use
GB9717158D0 (en) * 1997-08-13 1997-10-22 King S College London Solution synthesis of oligonucleotides and their phosphorothioate analogues
US6538128B1 (en) * 1997-09-08 2003-03-25 Avecia Biotechnology, Inc. Detritylation solvents for nucleic acid synthesis
US6184347B1 (en) 1998-11-19 2001-02-06 Agilent Technologies Inc. Minimization of blooming in high-density arrays by using reactive wash reagents
US6207819B1 (en) 1999-02-12 2001-03-27 Isis Pharmaceuticals, Inc. Compounds, processes and intermediates for synthesis of mixed backbone oligomeric compounds
US20040082774A1 (en) * 1999-03-16 2004-04-29 Guzaev Andrei P. Novel phosphate and thiophosphate protecting groups
US6121437A (en) 1999-03-16 2000-09-19 Isis Pharmaceuticals, Inc. Phosphate and thiophosphate protecting groups
EP2314693A3 (en) 1999-08-13 2012-11-28 Idera Pharmaceuticals, Inc. Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides
US20010011126A1 (en) * 1999-09-10 2001-08-02 Bock Elisabeth Marianne Neurogenic compositions and methods
US6620796B1 (en) * 1999-11-08 2003-09-16 Micrologix Biotech Inc. Combinatorial library synthesis and pharmaceutically active compounds produced thereby
CA2398432C (en) * 2000-01-26 2012-06-19 Hybridon, Inc. Modulation of oligonucleotide cpg-mediated immune stimulation by positional modification of nucleosides
WO2001074346A2 (en) * 2000-04-03 2001-10-11 Hybridon, Inc. Sensitization of cells to cytotoxic agents using oligonucleotides directed to nucleotide excision repair or transcritpion coupled repair genes
AU5736601A (en) 2000-05-01 2001-11-12 Hybridon Inc Modulation of oligonucleotide cpg-mediated immune stimulation by positional modification of nucleosides
US6809195B1 (en) * 2000-08-16 2004-10-26 Isis Pharmaceuticals, Inc. Process for the preparation of oligonucleotides
AU2001294750C1 (en) * 2000-09-26 2008-09-18 Idera Pharmaceuticals, Inc. Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
US20030072689A1 (en) * 2001-08-15 2003-04-17 Third Wave Technologies, Inc. Polymer synthesizer
US6932943B1 (en) 2001-01-26 2005-08-23 Third Wave Technologies Nucleic acid synthesizers
US7435390B2 (en) * 2001-01-26 2008-10-14 Third Wave Technologies, Inc. Nucleic acid synthesizers
US20080261220A1 (en) * 2000-11-30 2008-10-23 Third Wave Technologies, Inc. Nucleic Acid Detection Assays
US6825338B2 (en) 2001-03-30 2004-11-30 Isis Pharmaceuticals, Inc. Labeled oligonucleotides, methods for making same, and compounds useful therefor
US7105495B2 (en) * 2001-04-30 2006-09-12 Idera Pharmaceuticals, Inc. Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides
WO2002092006A2 (en) 2001-05-16 2002-11-21 Micrologix Biotech, Inc. Nucleic acid-based compounds and methods of use thereof
US6921812B1 (en) 2001-07-03 2005-07-26 Isis Pharmaceuticals, Inc. Methods of modulating pharmacokinetics of oligonucleotides
US7276489B2 (en) * 2002-10-24 2007-10-02 Idera Pharmaceuticals, Inc. Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
US20040009483A1 (en) * 2002-07-12 2004-01-15 Ilsley Diane D. Method of linear mRNA amplification using total RNA
CA2512484A1 (en) * 2003-01-16 2004-05-08 Hybridon, Inc. Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
CA2549173A1 (en) 2003-12-08 2005-07-07 Hybridon, Inc. Modulation of immunostimulatory properties by small oligonucleotide-based compounds
US7776834B2 (en) * 2005-11-07 2010-08-17 Idera Pharmaceuticals, Inc. Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides
EP2371956A3 (en) 2005-11-07 2012-01-04 Idera Pharmaceuticals Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides
US7470674B2 (en) * 2005-11-07 2008-12-30 Idera Pharmaceuticals, Inc. Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides
US20070255054A1 (en) * 2005-12-30 2007-11-01 Affymetrix, Inc. Oligonucleotide synthesis with intermittent and post synthetic oxidation
WO2009117327A2 (en) * 2008-03-15 2009-09-24 Hologic, Inc. Compositions and methods for analysis of nucleic acid molecules during amplification reactions
WO2014158628A1 (en) 2013-03-14 2014-10-02 Hologic, Inc. Compositions and methods for analysis of nucleic acid molecules
CN120442758A (zh) 2021-09-30 2025-08-08 简·探针公司 可温度选择的fret盒信号传导

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4959463A (en) * 1985-10-15 1990-09-25 Genentech, Inc. Intermediates

Also Published As

Publication number Publication date
WO1990012024A1 (en) 1990-10-18
EP0593422A1 (en) 1994-04-27
ATE137760T1 (de) 1996-05-15
DK0593422T3 (da) 1996-07-29
CA2051692A1 (en) 1990-10-07
BR9007268A (pt) 1992-03-17
DE69026963D1 (de) 1996-06-13
DE69026963T2 (de) 1996-11-07
EP0593422B1 (en) 1996-05-08
JPH04504420A (ja) 1992-08-06
US5149798A (en) 1992-09-22

Similar Documents

Publication Publication Date Title
ES2089014T3 (es) Metodo de sintesis de oligonucleotidos adaptable a la sintesis en gran escala.
PT693065E (pt) Derivados de cumarina nao-nucleosidicos como agentes reticulantes de polionucleotidos
DK0517796T3 (da) Oligonukleotid-analoger
ATE49977T1 (de) Herstellung von dna in grossem umfang.
FR2703359B1 (fr) Copolymère nucléotide(s)/polymère conducteur électronique ; son procédé de préparation et son utilisation .
Praseuth et al. Double helices with parallel strands are formed by nuclease-resistant oligo-[α]-deoxynucleotides and oligo-[α]-deoxynucleotides covalently linked to an intercalating agent with complementary oligo-[β]-deoxynucleotides
IT1247472B (it) Processo per la preparazione di microsfere contenenti componenti biologicamente attivi.
DE69521517D1 (de) Prodrug-oligonukleotide
DE69233331D1 (de) Kombinatorische Strategien für Polymersynthese
KR910008132A (ko) 자기 가공 활성을 갖는 다기능 rna, 이의 제조방법 및 용도
EP0971943A4 (en) NUCLEIC ACID CONTAINING POLYMERIZABLE COMPLEX
OA06505A (fr) Procédé d'inclusion de micro-organismes dans une matrice de polymère.
BR8804933A (pt) Material celular poroso,suporte biologico e processo para a preparacao de um material poroso
BR9901320A (pt) Composição modificadora de impacto núcleo-casca, mistura lìmpida, e, artigos produzidos a partir da mistura.
YU46903B (sh) Postupak za dobijanje polimernog vlakna, koje sadrži lek, za zadržavanje u gastrointestinalnom traktu
ES2145958T3 (es) Procedimiento continuo para la preparacion de 4-amino-2,2,6,6-tetrametilpiperidina.
MX9207381A (es) Proceso para la fabricacion de polimeros de diolefina conjugadas, selectivamente hidrogenados.
ES2080185T3 (es) Procedimiento para la produccion continua en masa de polimeros acrilicos.
ES2077019T3 (es) Preparacion de polimeros de monoxido de carbono con compuestos insaturados.
ATE34773T1 (de) Verfahren zur reinigung von laktulose.
KR910008136A (ko) 엔도뉴클라제 및 안티쎈스 활성을 갖는 rna, 이의 제조방법 및 용도
JPS6420319A (en) Polyester fiber
FR2835836B1 (fr) Metallocenes bifonctionnalises, procede d'obtention, utilisation pour le marquage de molecules biologiques
JPS556918A (en) Polling control system
BR8805393A (pt) Polimeros funcionalizados do etileno aplicaveis ao revestimento de um metal e processo para sua preparacao e obtencao do material complexo

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 593422

Country of ref document: ES

FG2A Definitive protection

Ref document number: 593422

Country of ref document: ES